HOME >> BIOLOGY >> NEWS
Bioinformatics: The quest for new drugs finds significant profits

NEW YORK--July 31, 2002-- Bioinformatics, a combination of information technology (IT) and biological sciences, is being recognized as a critical component of drug discovery by both pharmaceutical and pure IT companies.

"With the massive quantities of data now available to researchers, computers have become essential," says Technical Insights Analyst Katherine Austin. "However, having the data in the computer does not mean that it can be used in any meaningful way. The challenge for bioinformatics developers is to design platforms that can manage, retrieve, organize, compare, manipulate, and integrate data in a way that accelerates research, rather than acting as a bottleneck."

The discovery of new drugs means substantial profits, making bioinformatics a bright new field. Bioinformatics and molecular modeling technologies have the potential, within three to five years, to hugely decrease the risk, cost, and expertise required for the early stages of drug development--target selection and validation.

A significant application of bioinformatics is in silico discovery, which is the collection of data to substantiate targets and better the chances that a particular drug lead will be successful. This technology sorts and organizes data to enable scientists to identify potential drug targets, disease susceptibility, drug toxicity and efficacy, as well as individual responses to medication.

In addition, computer modeling of molecular structure can aid researchers in optimizing a potential drug lead, by allowing them to observe the effects of structural changes without expensive wet-lab experiments. If two or three targets result in marketable drugs, it will be a very profitable investment for pharmaceutical companies.

Success in the bioinformatics market depends on improved integration and interoperability among different software vendors, database providers, computer hardware, and in-house compilations. Developers need to focus
'"/>

Contact: Julia Rowell
jrowell@frost.com
210-247-3870
Technical Insights
31-Jul-2002


Page: 1 2

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. NSF announces six FIBR awards to tackle some of biologys most challenging questions
3. Two-month study of life in mid-Atlantic yields trove of species, new insights & questions
4. U of T research answers key question in biochemistry
5. Symposium to tackle questions of genetic engineering and biodiversity
6. Confidentiality of genetic databases questioned by Stanford researchers
7. Bacteria spill their guts to aid researchers in quest for new antibiotics
8. NAS requests nominations for outstanding scientists
9. Antibiotic resistance risk from triclosan questioned
10. IU and Purdue scientists to answer questions about Brood X periodical cicadas
11. K-State soil carbon sequestration research playing role in climate change efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The ... been published and is now available on the company’s global website. Crystallography Times—an ... analysis community, presenting current news and crystallographic research. , The latest issue ...
(Date:8/21/2020)... CARLSBAD, Calif. (PRWEB) , ... August 19, 2020 ... ... of both Salimetrics LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for ... co-editor of the recently published book by Springer, " Salivary Bioscience: Foundations of ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman Carl ... executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and ... Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... software for the life sciences industry, today announced the release of its ... specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
Breaking Biology Technology:
Cached News: